Yam, Jason C

Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control. [electronic resource] - Ophthalmology 01 2019 - 113-124 p. digital

Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1549-4713

10.1016/j.ophtha.2018.05.029 doi


Accommodation, Ocular--physiology
Administration, Ophthalmic
Atropine--administration & dosage
Axial Length, Eye
Child
Child, Preschool
Disease Progression
Dose-Response Relationship, Drug
Double-Blind Method
Female
Humans
Male
Muscarinic Antagonists--administration & dosage
Myopia--diagnosis
Ophthalmic Solutions
Quality of Life
Refraction, Ocular--physiology
Surveys and Questionnaires
Vision Tests
Visual Acuity--physiology